DK0705099T3 - Anvendelse af modafinil til behandling af søvnapnø og åndedrætslidelser af central oprindelse - Google Patents

Anvendelse af modafinil til behandling af søvnapnø og åndedrætslidelser af central oprindelse

Info

Publication number
DK0705099T3
DK0705099T3 DK94919708T DK94919708T DK0705099T3 DK 0705099 T3 DK0705099 T3 DK 0705099T3 DK 94919708 T DK94919708 T DK 94919708T DK 94919708 T DK94919708 T DK 94919708T DK 0705099 T3 DK0705099 T3 DK 0705099T3
Authority
DK
Denmark
Prior art keywords
modafinil
treatment
sleep apnea
pct
central origin
Prior art date
Application number
DK94919708T
Other languages
Danish (da)
English (en)
Inventor
Philippe Laurent
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9448411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0705099(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lafon Labor filed Critical Lafon Labor
Application granted granted Critical
Publication of DK0705099T3 publication Critical patent/DK0705099T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
DK94919708T 1993-06-22 1994-06-14 Anvendelse af modafinil til behandling af søvnapnø og åndedrætslidelser af central oprindelse DK0705099T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9307555A FR2706767B1 (online.php) 1993-06-22 1993-06-22
PCT/FR1994/000711 WO1995000132A1 (fr) 1993-06-22 1994-06-14 Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale

Publications (1)

Publication Number Publication Date
DK0705099T3 true DK0705099T3 (da) 2002-02-11

Family

ID=9448411

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94919708T DK0705099T3 (da) 1993-06-22 1994-06-14 Anvendelse af modafinil til behandling af søvnapnø og åndedrætslidelser af central oprindelse

Country Status (14)

Country Link
US (1) US5612379A (online.php)
EP (1) EP0705099B1 (online.php)
JP (1) JP3703831B2 (online.php)
KR (1) KR100315389B1 (online.php)
AT (1) ATE207351T1 (online.php)
AU (1) AU684087B2 (online.php)
CA (1) CA2165824C (online.php)
DE (1) DE69428791T2 (online.php)
DK (1) DK0705099T3 (online.php)
ES (1) ES2165878T3 (online.php)
FR (1) FR2706767B1 (online.php)
HU (1) HU216731B (online.php)
PT (1) PT705099E (online.php)
WO (1) WO1995000132A1 (online.php)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
CA2321900C (en) 1998-02-27 2011-07-19 The Board Of Trustees Of The University Of Illinois Agents with serotonin-related activity for the treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
DE60137069D1 (de) * 2000-10-11 2009-01-29 Cephalon Inc Arzneizusammensetzungen enthaltend modafinilverbindungen
IL158959A (en) * 2001-05-25 2010-06-30 Cephalon Inc Solid pharmaceutical formulations comprising modafinil
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
US7528172B2 (en) * 2003-01-21 2009-05-05 The Cooper Health System, Inc. Compositions and methods for improving recovery after general anesthesia
WO2004082630A2 (en) * 2003-03-17 2004-09-30 Neurohealing Pharmaceuticals, Inc. High potency dopaminergic treatment of neurological impairment associated with brain injury
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
CA2590802A1 (en) * 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
US20090123545A1 (en) * 2005-07-21 2009-05-14 Ron Eyal S Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof
MX2009000391A (es) * 2006-07-12 2009-06-30 Elan Pharma Int Ltd Formulación de modafinilo en forma de nano-partículas.
CA2660565C (en) * 2006-08-14 2012-10-09 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
US20110224196A1 (en) * 2010-01-07 2011-09-15 Vivus, Inc. Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
US10709749B2 (en) 2013-08-30 2020-07-14 Green Cross Wellbeing Corporation Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
CA2165824C (fr) 2005-08-02
FR2706767A1 (online.php) 1994-12-30
HUT74674A (en) 1997-01-28
KR100315389B1 (ko) 2002-02-19
US5612379A (en) 1997-03-18
KR960703009A (ko) 1996-06-19
AU684087B2 (en) 1997-12-04
EP0705099A1 (fr) 1996-04-10
JP3703831B2 (ja) 2005-10-05
DE69428791T2 (de) 2002-07-04
CA2165824A1 (fr) 1995-01-05
AU7076094A (en) 1995-01-17
ATE207351T1 (de) 2001-11-15
WO1995000132A1 (fr) 1995-01-05
HU216731B (hu) 1999-08-30
JPH09500374A (ja) 1997-01-14
DE69428791D1 (de) 2001-11-29
EP0705099B1 (fr) 2001-10-24
HU9503702D0 (en) 1996-02-28
ES2165878T3 (es) 2002-04-01
PT705099E (pt) 2002-03-28
FR2706767B1 (online.php) 1995-09-08

Similar Documents

Publication Publication Date Title
HU9503702D0 (en) Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
GB0223038D0 (en) Therapeutic compounds
MXPA03010232A (es) Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
DK0705244T3 (da) Nitrato-aminosyredisulfid til behandling af sygdomme i det cardiovaskulære system
IL108769A0 (en) Spirocyclic piperidine derivatives
NO953187D0 (no) Imidazopyridiner og deres anvendelse ved behandling av mave-tarm-sykdommer
NO976048D0 (no) Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
ATE245977T1 (de) Therapeutische substituierte guanidine
NO970161D0 (no) Triazolforbindelser og anvendelse derav
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
NO20054744L (no) Behandling av Alzheimers sykdom
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
MY139368A (en) Novel cyclohexyl sulphones
TR200200278T2 (tr) Kalsilitik bileşimler
NO952559L (no) N-acyl-pyrrolidiner og medikamenter for behandling eller prevensjon av cholecystokinin- og gastrin-relaterte mangler
NO952427D0 (no) Metode for behandling av kronisk prostatitt med 17 substituerte karbamoyl-4-aza-5
ATE239458T1 (de) Verwendung von selegilin zur behandlung von epileptischen erkrankungen
AU2003283011A1 (en) Spirocyclopropyl amides and acids and their therapeutic applications
DK0707477T3 (da) Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo
UA83017C2 (uk) Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів
PL375354A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
SE9403861D0 (sv) Novel medicinal use